Sowell Financial Services LLC Crispr Therapeutics Ag Transaction History

Sowell Financial Services LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$100.84 - $161.89 $72,100 - $115,751	-715 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$110.72 - $210.04 $17,936 - $34,026	162 Added 29.29%	715 $77,000
Q4 2020 Jan 13, 2021	BUY	$79.67 - $173.23 $4,859 - $10,567	61 Added 12.4%	553 $85,000
Q3 2020 Nov 12, 2020	BUY	$78.5 - $100.64 $9,420 - $12,076	120 Added 32.26%	492 $41,000
Q2 2020 Aug 13, 2020	BUY	$38.5 - $76.05 $2,579 - $5,095	67 Added 21.97%	372 $27,000
Q1 2020 May 12, 2020	BUY	$33.68 - $62.53 $6,567 - $12,193	195 Added 177.27%	305 $13,000
Q4 2019 Feb 07, 2020	BUY	$36.68 - $73.13 $2,200 - $4,387	60 Added 120.0%	110 $6,000
Q3 2019 Nov 14, 2019	BUY	$40.99 - $52.56 $2,049 - $2,628	50 New	50 $2,000

491

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.74B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.